209 related articles for article (PubMed ID: 18832029)
1. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design.
Guo C; Stine KJ; Kauffman JF; Doub WH
Eur J Pharm Sci; 2008 Dec; 35(5):417-26. PubMed ID: 18832029
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
AAPS PharmSciTech; 2011 Mar; 12(1):337-43. PubMed ID: 21286880
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of Formulation and Delivery Device-Related Effects on In Vitro Performance of Nasal Spray with Implication to Rational Product Specification Identification.
Grmaš J; Stare K; Božič D; Injac R; Dreu R
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):230-246. PubMed ID: 28075184
[TBL] [Abstract][Full Text] [Related]
4. The influence of actuation parameters on in vitro testing of nasal spray products.
Guo C; Doub WH
J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
[TBL] [Abstract][Full Text] [Related]
5. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: part I. Model prediction using Monte Carlo simulation.
Guo C; Doub WH; Kauffman JF
J Pharm Sci; 2010 Apr; 99(4):2114-22. PubMed ID: 19902528
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
Dayal P; Shaik MS; Singh M
J Pharm Sci; 2004 Jul; 93(7):1725-42. PubMed ID: 15176062
[TBL] [Abstract][Full Text] [Related]
7. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension.
Dayal P; Pillay V; Babu RJ; Singh M
AAPS PharmSciTech; 2005 Nov; 6(4):E573-85. PubMed ID: 16408859
[TBL] [Abstract][Full Text] [Related]
8. The influence of spray properties on intranasal deposition.
Foo MY; Cheng YS; Su WC; Donovan MD
J Aerosol Med; 2007; 20(4):495-508. PubMed ID: 18158721
[TBL] [Abstract][Full Text] [Related]
9. Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray.
Doughty DV; Hsu W; Dalby RN
Drug Dev Ind Pharm; 2014 Jun; 40(6):711-8. PubMed ID: 23594299
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of droplet velocity and size from nasal spray devices using phase Doppler anemometry (PDA).
Liu X; Doub WH; Guo C
Int J Pharm; 2010 Mar; 388(1-2):82-7. PubMed ID: 20043981
[TBL] [Abstract][Full Text] [Related]
11. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure.
Inthavong K; Fung MC; Yang W; Tu J
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):59-67. PubMed ID: 24914675
[TBL] [Abstract][Full Text] [Related]
12. Use of flexible weighted nasal spray dip tubes to improve product performance.
Doughty DV; Diao L; Hoag SW; Dalby RN
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):69-75. PubMed ID: 19778208
[TBL] [Abstract][Full Text] [Related]
13. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Pitta SK; Dudhipala N; Narala A; Veerabrahma K
Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of impaction force of nasal sprays and metered-dose inhalers using the Texture Analyser.
Guo C; Ye W; Kauffman J; Doub WH
J Pharm Sci; 2009 Aug; 98(8):2799-806. PubMed ID: 19097159
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery to the nasal cavity: in vitro and in vivo assessment.
Newman SP; Pitcairn GR; Dalby RN
Crit Rev Ther Drug Carrier Syst; 2004; 21(1):21-66. PubMed ID: 15099184
[TBL] [Abstract][Full Text] [Related]
16. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.
Kundoor V; Dalby RN
Pharm Res; 2011 Aug; 28(8):1895-904. PubMed ID: 21499839
[TBL] [Abstract][Full Text] [Related]
17. Effects of nasal drug delivery device and its orientation on sprayed particle deposition in a realistic human nasal cavity.
Tong X; Dong J; Shang Y; Inthavong K; Tu J
Comput Biol Med; 2016 Oct; 77():40-8. PubMed ID: 27509293
[TBL] [Abstract][Full Text] [Related]
18. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
[TBL] [Abstract][Full Text] [Related]
19. Analytical challenges and regulatory requirements for nasal drug products in europe and the u.s.
Trows S; Wuchner K; Spycher R; Steckel H
Pharmaceutics; 2014 Apr; 6(2):195-219. PubMed ID: 24732068
[TBL] [Abstract][Full Text] [Related]
20. Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region.
Kolanjiyil AV; Walenga R; Babiskin A; Golshahi L; Hindle M; Longest W
Int J Pharm; 2023 Mar; 635():122718. PubMed ID: 36781083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
